The development of experimental allergic encephalomyelitis with immunizing doses of myelin basic protein.
Rabbits immunized with low (11.25 mg) and high (57.50 mg) doses of myelin basic protein from several species develop antibasic protein antibodies, delayed type hypersensitivity, and clinical and pathological signs of experimental allergic encephalomyelitis. More than 55% of rabbits immunized with relatively high doses of basic protein develop disease. The absence of circulating antibasic protein antibodies in immunorespondent animals is associated with the appearance of clinical or histological signs of experimental allergic encephalomyelitis; however, the presence of humoral antibodies did not prevent completely the development of disease. Delayed-type hypersensitivity, specific for the basic protein, appears as early as 5 days after immunization and is maintained in nondiseased and surviving animals. Neither excess encephalitogen nor encephalitogen-induced antibody is sufficient to suppress completely the eventual development of clinical or histological manifestations of disease.
D000818:Animals; D000917:Antibody Formation; D001921:Brain / Q000473:pathology; D004681:Encephalomyelitis, Autoimmune, Experimental / Q000209:etiology* / Q000276:immunology / Q000473:pathology; D006968:Hypersensitivity, Delayed; D007115:Immunization Schedule; D005779:Immunodiffusion; D007271:Injections, Intradermal; D007275:Injections, Intravenous; D007279:Injections, Subcutaneous; D008297:Male; D004676:Myelin Basic Protein / Q000008:administration & dosage; D009186:Myelin Sheath / Q000032:analysis*; D011817:Rabbits; D012882:Skin Tests; D013116:Spinal Cord / Q000473:pathology; D013997:Time Factors
D004676:Myelin Basic Protein